Silk Road Medical Company

Silk Road Medical provides research and development services of medical devices for neurovascular diseases.
Silk Road Medical believes that by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with arterial disease. Our history is one of deep collaboration with vascular surgeons and our future will be guided by continuous learning, observation, and improvement. Silk Road advances patient care. Silk Road Medical Inc. was founded in 2007 and is based in Sunnyvale, California.
Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke.

Investors

Total Funding: $160.6M
Headquarters: Others
Funding Status: IPO
Employee Number: 11-50
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Last Funding Type: Series C
Number Of Exists: N/A
Technology: Health Application
Investor Type: N/A
Investors Number: 5
Founded Date: 2007
Industry: AgeTech
Register and Claim Ownership